Quintana-Hernández DJ

Asociación Científica Psicodélica, Arucas, Spain.

8 papers · ORCID

ArticlePsychedelics

Understanding treatment expectations toward emerging therapies in veterinary medicine: the role of knowledge, attitudes, and beliefs toward psychedelic-assisted interventions.

Suárez-Fernández Y, Hernández-Álvarez E, Borkel LF +3

Europe PMC2026
ArticleLSD

Preliminary Findings on Low-Dose 1cp-LSD for Canine Anxiety: Exploring the Role of Owner Neuroticism and Psychopathology.

Hernández-Álvarez E, Rojas-Hernández J, Borkel LF +3

Europe PMC2025
ArticlePsilocybin

The Causal Role of Consciousness in Psychedelic Therapy for Treatment-Resistant Depression: Hypothesis and Proposal.

Fernández-Borkel T, Borkel LF, Rojas-Hernández J +4

Europe PMC2025
ArticleLSD

Evaluating the Potential of Microdosing 1cp-LSD for the Treatment of Canine Anxiety: A One-Month Case Study.

Hernández-Álvarez E, Borkel LF, Rojas-Hernández J +5

Europe PMC2025
ArticlePsychedelics

Therapeutic benefit versus epistemic risk: Need for empirical research in psychedelic epistemology.

Borkel LF, Rojas-Hernández J, Quintana-Hernández DJ +1

Europe PMC2025
ArticleLSD

Single-dose 1cp-LSD administration for canine anxiety: a pilot study.

Henríquez-Hernández LA, García-Serrano I, Quintana-Hernández DJ +5

Europe PMC2024
ArticlePsilocybin

Set and setting predict psychopathology, wellbeing and meaningfulness of psychedelic experiences: a correlational study.

Borkel LF, Rojas-Hernández J, Henríquez-Hernández LA +2

Europe PMC2024
ArticlePsilocybin

Hofmann vs. Paracelsus: Do Psychedelics Defy the Basics of Toxicology?-A Systematic Review of the Main Ergolamines, Simple Tryptamines, and Phenylethylamines.

Henríquez-Hernández LA, Rojas-Hernández J, Quintana-Hernández DJ +1

Europe PMC2023